| Stage | ACA | % of rev | NWE | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $659M | 100.00% | $393M | 100.00% | ACA ×1.68 |
| Gross profit | $156M | 23.64% | $224M | 56.97% | NWE +33.3pp |
| Operating income | $84M | 12.80% | $64M | 16.36% | NWE +3.6pp |
| Pre-tax income | $62M | 9.46% | $28M | 7.25% | ACA +2.2pp |
| Net income | $329M | 49.87% | $25M | 6.37% | ACA +43.5pp |
| Stage | ACA | NWE | Gap · A − B |
|---|---|---|---|
| Revenue | $659M100.00% | $393M100.00% | ACA ×1.68 |
| Gross profit | 23.64%$156M | 56.97%$224M | NWE +33.3pp |
| Operating income | 12.80%$84M | 16.36%$64M | NWE +3.6pp |
| Pre-tax income | 9.46%$62M | 7.25%$28M | ACA +2.2pp |
| Net income | 49.87%$329M | 6.37%$25M | ACA +43.5pp |
No shared counterparties.